User profiles for Stephen C Resch

Stephen Resch

Lecturer on Health Decision Science, Harvard School of Public Health
Verified email at harvard.edu
Cited by 5767

Simulation of growth trajectories of childhood obesity into adulthood

ZJ Ward, MW Long, SC Resch, CM Giles… - … England Journal of …, 2017 - Mass Medical Soc
Background Although the current obesity epidemic has been well documented in children
and adults, less is known about long-term risks of adult obesity for a given child at his or her …

Cost-effectiveness of surgery and its policy implications for global health: a systematic review and analysis

…, M Mandigo, L Hagander, SC Resch… - The Lancet Global …, 2014 - thelancet.com
Background The perception of surgery as expensive and complex might be a barrier to its
widespread acceptance in global health efforts. We did a systematic review and analysis of …

Three interventions that reduce childhood obesity are projected to save more than they cost to implement

…, EL Kenney, KR Sonneville, AS Afzal, SC Resch… - Health …, 2015 - healthaffairs.org
Policy makers seeking to reduce childhood obesity must prioritize investment in treatment
and primary prevention. We estimated the cost-effectiveness of seven interventions high on …

Cost effectiveness of a sugar-sweetened beverage excise tax in the US

MW Long, SL Gortmaker, ZJ Ward, SC Resch… - American journal of …, 2015 - Elsevier
Introduction Reducing sugar-sweetened beverage consumption through taxation is a
promising public health response to the obesity epidemic in the US This study quantifies the …

Cost effectiveness of childhood obesity interventions: evidence and methods for CHOICES

SL Gortmaker, MW Long, SC Resch, ZJ Ward… - American journal of …, 2015 - Elsevier
Introduction The childhood obesity epidemic continues in the US, and fiscal crises are leading
policymakers to ask not only whether an intervention works but also whether it offers value …

Cost-effectiveness of treating multidrug-resistant tuberculosis

SC Resch, JA Salomon, M Murray… - PLoS medicine, 2006 - journals.plos.org
Background Despite the existence of effective drug treatments, tuberculosis (TB) causes 2
million deaths annually worldwide. Effective treatment is complicated by multidrug-resistant …

The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs

JMS Lin, SC Resch, DJ Brimmer, A Johnson… - Cost Effectiveness and …, 2011 - Springer
Background Chronic fatigue syndrome (CFS) is a debilitating chronic illness affecting at least
4 million people in the United States. Understanding its cost improves decisions regarding …

Redrawing the US obesity landscape: bias-corrected estimates of state-specific adult obesity prevalence

…, SC Resch, SL Gortmaker, AL Cradock, C Giles… - PloS one, 2016 - journals.plos.org
Background State-level estimates from the Centers for Disease Control and Prevention (CDC)
underestimate the obesity epidemic because they use self-reported height and weight. …

Using cost-effectiveness analysis to prioritize policy and programmatic approaches to physical activity promotion and obesity prevention in childhood

…, CM Giles, ZJ Ward, MW Long, SC Resch… - Preventive …, 2017 - Elsevier
Participation in recommended levels of physical activity promotes a healthy body weight and
reduced chronic disease risk. To inform investment in prevention initiatives, we simulate the …

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: cost-effectiveness analysis for India's public sector

DJ Lee, N Kumarasamy, SC Resch… - PLoS …, 2019 - journals.plos.org
Background Truenat is a novel molecular assay that rapidly detects tuberculosis (TB) and
rifampicin-resistance. Due to the portability of its battery-powered testing platform, it may be …